Intelligence / Healthtech / De Novo Grants / Auris Health, Inc., part of Johnson & Johnson MedTech
Approvalsnovel device granted (FDA De Novo)21 Jul 2026
Auris Health, Inc., part of Johnson & Johnson MedTech
21 Jul 2026: Novel device granted (FDA De Novo) · OTTAVA Robotic Surgical System. Recorded in the openFDA device 510(k) (De Novo decisions).
- Granted
- 21 Jul 2026
- Device
- OTTAVA Robotic Surgical System
- Specialty
- General, Plastic Surgery
- Product Code
- SIR
- Country
- United States
- Location
- Santa Clara, CA
- Submitted
- 2025-12-18
- Reference
- DEN250068
What this signal means
A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.
- 2 added in the 30 days to 19 Nov 2026.
- Neurology leads (10); 29% went to makers outside the US.
Reach them with AOS
Find the decision makers at Auris Health, Inc., part of Johnson & Johnson MedTech
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
More in General, Plastic Surgery
De Novo Grants
30 OctVirtuoso Surgical, Inc.novel device granted (FDA De Novo) · Virtuoso Endoscopy SystemApprovals21 MaySpectralmd, Inc.novel device granted (FDA De Novo) · DeepView AI® SystemApprovals6 FebAmferia ABnovel device granted (FDA De Novo) · Amferia Wound DressingApprovals3 OctIcecure Medicalnovel device granted (FDA De Novo) · ProSense SystemApprovals
Source: openFDA device 510(k) (De Novo decisions), data to 19 Nov 2026. Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code. AOS shows what the public record says; it does not verify or endorse the company.